Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Pøhl

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Tissue Antigens|March 21, 2014
SSX2-4 expression in early-stage non-small cell lung cancerK B V Greve, M Pøhl, K E Olsen, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 21, 2024
Early Mortality After Curative-intent Radiotherapy in Patients With Locally Advanced Non-small Cell Lung Cancer-A Population-based Cohort StudyK H Jensen, G Persson, M Pøhl, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 14, 2022
Thorough design and pre-trial quality assurance (QA) decrease dosimetric impact of delineation and dose planning variability in the STRICTLUNG and STARLUNG trials for stereotactic body radiotherapy (SBRT) of central and ultra-central lung tumoursL Hoffmann, G F Persson, L Nygård, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 26, 2023
Machine learning-based immune phenotypes correlate with STK11/KEAP1 co-mutations and prognosis in resectable NSCLC: a sub-study of the TNM-I trialM Rakaee, S Andersen, K Giannikou, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Tissue Antigens|March 21, 2014
SSX2-4 expression in early-stage non-small cell lung cancerK B V Greve, M Pøhl, K E Olsen, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 21, 2024
Early Mortality After Curative-intent Radiotherapy in Patients With Locally Advanced Non-small Cell Lung Cancer-A Population-based Cohort StudyK H Jensen, G Persson, M Pøhl, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 14, 2022
Thorough design and pre-trial quality assurance (QA) decrease dosimetric impact of delineation and dose planning variability in the STRICTLUNG and STARLUNG trials for stereotactic body radiotherapy (SBRT) of central and ultra-central lung tumoursL Hoffmann, G F Persson, L Nygård, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 26, 2023
Machine learning-based immune phenotypes correlate with STK11/KEAP1 co-mutations and prognosis in resectable NSCLC: a sub-study of the TNM-I trialM Rakaee, S Andersen, K Giannikou, et al.
Pageof 1